HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carson Products eyeing Ivax' Johnson Products as potential acquisition.

This article was originally published in The Rose Sheet

Executive Summary

IVAX PLANS TO DIVEST JOHNSON PRODUCTS PERSONAL CARE BUSINESS will allow the generic drugs company to focus on its core pharmaceutical business, the company announced July 25. The personal care segment is one of several units the Miami-based company has sold or is planning to sell. Ivax divested its intravenous drugs division to B. Braun in June and portions of its specialty chemicals business to CPAC and Sybron Chemicals in July. In total, the divested businesses registered income of $7.4 mil. in the second quarter.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel